| 1 |
31886861 | Adherence to statin therapy favours survival of patients with symptomatic peripheral artery disease. | 2021 Jul 23 |
1 |
| 2 |
31955599 | Low Density Lipoprotein Cholesterol-Lowering Strategies and Population Health: Time to Move to a Cumulative Exposure Model. | 2020 Mar 17 |
1 |
| 3 |
31957803 | SULT2B1b inhibits reverse cholesterol transport and promotes cholesterol accumulation and inflammation in lymphocytes from AMI patients with low LDL-C levels. | 2020 Jan 31 |
1 |
| 4 |
32040442 | LDL-C plays a causal role on T2DM: a Mendelian randomization analysis. | 2020 Feb 10 |
1 |
| 5 |
31861037 | The low-density lipoprotein cholesterol lowering is an ineffective surrogate marker of statin responsiveness to predict cardiovascular outcomes: The 10-year experience of matched population (a STROBE-compliant article). | 2019 Dec |
2 |
| 6 |
29233637 | Compound heterozygous familial hypercholesterolemia in a Chinese boy with a de novo and transmitted low-density lipoprotein receptor mutation. | 2018 Jan - Feb |
1 |
| 7 |
28291866 | Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial. | 2017 May 1 |
3 |
| 8 |
28599257 | Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care. | 2017 Aug |
2 |
| 9 |
28711708 | Ezetimibe and simvastatin combination inhibits and reverses the pro-inflammatory and pro-atherogenic effects of cream in obese patients. | 2017 Aug |
1 |
| 10 |
27454615 | Factors influencing low-density lipoprotein cholesterol target achievement in primary care - Results from DYSIS China. | 2016 Nov 1 |
1 |
| 11 |
25626487 | Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom. | 2015 Apr 1 |
7 |
| 12 |
26032258 | Statin treatment decreases serum angiostatin levels in patients with ischemic heart disease. | 2015 Aug 1 |
1 |
| 13 |
26638446 | [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?]. | 2015 Sep |
1 |
| 14 |
24528691 | Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease. | 2014 Jan-Feb |
3 |
| 15 |
24662777 | Effects of lipid-lowering drugs on high-density lipoprotein subclasses in healthy men-a randomized trial. | 2014 |
1 |
| 16 |
25066560 | Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population. | 2014 Aug |
1 |
| 17 |
25089134 | Influence of previous statin therapy on cholesterol-lowering effect of ezetimibe. | 2014 Jul |
1 |
| 18 |
25463129 | Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis. | 2014 Dec |
2 |
| 19 |
23100282 | Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study. | 2013 Apr |
1 |
| 20 |
23288881 | A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid-lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease. | 2013 May |
1 |
| 21 |
23776861 | The efficacy and safety of Simvastatin in the treatment of lipid abnormalities in diabetes mellitus. | 2013 Jan |
1 |
| 22 |
24265554 | Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy. | 2013 |
3 |
| 23 |
24380094 | Paradoxical negative HDL cholesterol response to atorvastatin and simvastatin treatment in Chinese type 2 diabetic patients. | 2013 Summer-Fall |
2 |
| 24 |
22668755 | Intronic variants in SLCO1B1 related to statin-induced myopathy are associated with the low-density lipoprotein cholesterol response to statins in Chinese patients with hyperlipidaemia. | 2012 Nov |
2 |
| 25 |
20519697 | CYP3AP1*3 allele is associated with lipid-lowering efficacy of simvastatin and atorvastatin in Chinese women. | 2011 Feb |
1 |
| 26 |
21189431 | Effect of hydroxymethylglutaryl-CoA reductase inhibitors on low-density lipoprotein cholesterol, interleukin-6, and high-sensitivity C-reactive protein in end-stage renal disease. | 2011 Jan |
2 |
| 27 |
21271793 | The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia. | 2011 Mar |
1 |
| 28 |
21349260 | Switching from statin monotherapy to ezetimibe/simvastatin or rosuvastatin modifies the relationships between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients at high risk of coronary disease. | 2011 Jun |
3 |
| 29 |
21385244 | Statins utilisation pattern: a retrospective evaluation in a tertiary care hospital in Thailand. | 2011 Apr |
1 |
| 30 |
21497705 | Combination therapy with ezetimibe/simvastatin versus statin monotherapy for low-density lipoprotein cholesterol reduction and goal attainment in a real-world clinical setting. | 2011 Feb |
2 |
| 31 |
21519514 | Comparison of Ezetimibe/Simvastatin 10/20 mg Versus Atorvastatin 20 mg in Achieving a Target Low Density Lipoprotein-Cholesterol Goal for Patients With Very High Risk. | 2011 Mar |
2 |
| 32 |
21559521 | Clinical use and effectiveness of lipid lowering therapies in diabetes mellitus--an observational study from the Swedish National Diabetes Register. | 2011 Apr 29 |
2 |
| 33 |
21699369 | Begin with the real-world patients of non-goal-achieved hypercholesterolemia in taiwan through the ezetimibe/simvastatin tablet - The BRAVO Study. | 2011 Aug |
2 |
| 34 |
21946898 | Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study. | 2011 Dec |
3 |
| 35 |
22027793 | [Rosuvastatin improves myocardial function and arteriosclerosis plaque in patients with ST-segment elevation after acute myocardial infarction and percutaneous coronary intervention]. | 2011 Oct |
1 |
| 36 |
22101558 | Intestinal sterol transporters and cholesterol absorption inhibition. | 2011 Dec |
1 |
| 37 |
19770794 | Switching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterol. | 2010 Mar-Apr |
5 |
| 38 |
19916706 | Therapy modifications and low-density lipoprotein cholesterol goal attainment rates associated with the initiation of generic simvastatin. | 2010 Jan |
1 |
| 39 |
19965915 | Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin. | 2010 Feb |
3 |
| 40 |
20203452 | LDL-C goal attainment in patients who remain on atorvastatin or switch to equivalent or non-equivalent doses of simvastatin: a retrospective matched cohort study in clinical practice. | 2010 Mar |
5 |
| 41 |
20487050 | Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets. | 2010 Jul |
1 |
| 42 |
20602615 | Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol? | 2010 Jul |
1 |
| 43 |
20653799 | Clinical and economic outcomes in patients switched to simvastatin in a community-based family medicine practice. | 2010 Aug |
2 |
| 44 |
20941469 | [High-dose statin therapy for high-risk patients]. | 2010 Oct |
1 |
| 45 |
21090830 | The cost effectiveness of statin therapies in Spain in 2010, after the introduction of generics and reference prices. | 2010 |
1 |
| 46 |
21122696 | Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients. | 2010 Nov-Dec |
4 |
| 47 |
21348380 | Efficacy and safety of ezetimibe and low-dose simvastatin as primary treatment for dyslipidemia in peritoneal dialysis patients. | 2010 |
1 |
| 48 |
19721860 | The efficacy and safety of ezetimibe and low-dose simvastatin as a primary treatment for dyslipidemia in renal transplant recipients. | 2009 Sep |
3 |
| 49 |
19745745 | A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial. | 2009 Dec |
1 |
| 50 |
19997842 | [Achievement of blood lipid target levels with Ezetimibe/Simvastatin in patients with atherosclerosis and/or diabetes mellitus--an Austrian observational study]. | 2009 |
3 |